Gracecast Lung Cancer Audio
ALK Inhibition: Science and Early Clinical Experience, by Dr. Ben Solomon (audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:17:29
- Mas informaciones
Informações:
Sinopsis
Dr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.
